Cynapsus Therapeutics company

Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson’s disease. The company specializes in the fields of healthcare, biotechnology, pharmaceutical, and therapeutics. It was founded in 2004 and headquartered in Toronto, Ontario.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Toronto, Ontario, Canada
Founded Date: 2004-01-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 3
Total Funding: $23.8M
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Equity

Visit Website
info@cynapsus.ca
Register and Claim Ownership